CD274 and familial pancreatic carcinoma: The study results of Herbst et al. 16 proved a discrepancy in PD-L1 expression between immune cells and tumour cells in several cancers, including melanoma, gastric cancer, NSCLC, renal cell carcinoma (RCC), head and neck squamous cell carcinoma (HNSCC), and pancreatic cancer.